Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Bradykinin B2 Receptors and Ileal Peristalsis
2026-09-03
The reference study established that bradykinin inhibits the peristaltic reflex in isolated guinea pig ileum through B2, rather than B1, kinin receptors. Its pressure-threshold assay, selective agonists, and antagonist comparisons provide a useful pharmacological framework for dissecting receptor control of gastrointestinal motility.
-
PEGylated PLGA Microspheres for Sustained Steroid Release
2026-09-03
Myers and Comolli developed PEGylated PLGA microspheres carrying hydrocortisone 17-butyrate and used release modeling to examine how surface modification changes corticosteroid delivery. The optimized formulation reached approximately 1.22 μm in diameter, achieved 71.98% entrapment efficiency, and reduced burst release while supporting diffusion-controlled release over three weeks.
-
MOB1A/B Loss Rewires Intestinal Wnt–BMP/TGF-β Signaling
2026-09-02
Bae et al. show that intestinal epithelial MOB1A/B depletion disrupts homeostasis through simultaneous Wnt suppression and BMP/TGF-β activation, despite an initial increase in epithelial proliferation. Pharmacological inhibition partially restores secretory-cell differentiation but not intestinal stem-cell pools, revealing distinct pathway requirements for epithelial maintenance.
-
Captopril Workflows for ACE and Bradykinin Research
2026-09-02
Captopril is more than an antihypertensive drug for blood pressure control: its defined ACE activity supports concentration-response, angiotensin pathway, and bradykinin-intersection experiments. This practical guide translates published ileum pharmacology into controlled assay designs while separating established evidence from testable oncology and gastrointestinal hypotheses.
-
Gastric Cancer Assembloids for Drug Response Modeling
2026-09-01
A 2025 study developed patient-derived gastric cancer assembloids by combining matched tumor organoids with stromal cell subpopulations from the same tumor. The model reproduced tumor heterogeneity, altered transcriptomic states and drug responses relative to organoid monocultures, providing a more physiologically relevant framework for resistance studies and personalized treatment research.
-
NHS-Biotin Workflows for Multimeric Protein Assays
2026-09-01
NHS-Biotin provides a compact, irreversible biotin tag for antibody, protein, and intracellular labeling workflows. Its utility extends from streptavidin-based detection and purification to studying peptidisc-stabilized nanobody assemblies without confusing labeling with the multimerization process itself.
-
MLKL Polymerization Drives Lysosomal Permeabilization
2026-08-31
The reference study identifies lysosomal membrane permeabilization as a critical intermediate in MLKL-mediated necroptosis. Its experiments show that MLKL polymerization damages lysosomes, releases active cathepsins, and makes cathepsin B a major contributor to the proteolytic destruction that precedes cell death.
-
Bispecific Antibodies for Broad Orthopoxvirus Protection
2026-08-31
The reference study maps anti-M1R and anti-B6R monoclonal antibodies and shows that selected cocktails and bispecific formats can improve antiviral activity against orthopoxviruses. Its most notable design, which inserts a VH-CH1 switch region into the bispecific architecture, produced strong protection against vaccinia virus in mice and provides a framework for broader antibody development.
-
ISRIB (trans-isomer) and Inflammation-Driven Forgetting
2026-08-30
ISRIB (trans-isomer) provides a mechanistic way to test how integrated stress response signaling accelerates inflammation-associated memory loss. This article translates recent mouse findings into practical molecular, behavioral, and ER stress research assay decisions.
-
Neuroligin 1 Proteolysis Sustains Social Memory
2026-08-29
The reference study identifies social interaction-induced proteolysis of Neuroligin 1 as a mechanism that maintains, rather than merely forms, social memory in mice. Its evidence links ventral hippocampal NLG1-CTD production to PDZ-domain signaling, cofilin regulation, dendritic spine maturation, and behavioral rescue.
-
M344 in Neuroblastoma: Mechanisms and Tumor Control
2026-08-28
The 2025 reference study shows that M344 increases histone acetylation, restricts neuroblastoma cell-cycle progression, activates caspase-mediated death, and suppresses tumor growth in vivo. Its comparison with vorinostat and evaluation alongside topotecan or cyclophosphamide provide a preclinical framework for developing less toxic, relapse-aware treatment strategies.
-
(-)-JQ1 Workflows for BET Control Studies
2026-08-28
(-)-JQ1 gives BET inhibition experiments a stereochemically matched negative control that helps separate BRD4-dependent effects from vehicle, scaffold, and assay artifacts. This workflow applies the control to AML transcriptional studies, including N-MYC/eIF4G1 investigations, while highlighting preparation, dosing, and troubleshooting decisions.
-
Anti-HMGB1 Rabbit Monoclonal Antibody Guide
2026-08-27
This dossier-based guide explains how to use the Anti-HMGB1 Rabbit Monoclonal Antibody (MA3057) for HMGB1 detection in Western blot, immunohistochemistry, and flow cytometry workflows. It is intended for controlled scientific research in human, mouse, and rat samples, not for diagnostic, therapeutic, or medical applications.
-
Sulfo-Cy5 NHS ester for Aqueous Imaging
2026-08-27
Sulfo-Cy5 NHS ester enables red/far-red labeling of amine-bearing proteins and peptides without relying on organic co-solvents during the reaction. Its water-compatible design supports solvent-sensitive biomolecules, VLA-4 imaging, and fluorescence assays that pair localization data with immune-cell functional readouts.
-
GM 6001 (Galardin) for ECM Research
2026-08-26
GM 6001 (Galardin) provides nanomolar-affinity, broad-spectrum MMP inhibition for controlled studies of extracellular matrix remodeling, tissue repair, signaling, and cell migration. This practical guide connects assay setup and troubleshooting with emerging evidence on perineuronal-net preservation in Alzheimer’s disease research.